Optimizing Heart Failure Care in Pakistan : Lessons From UAE Cardiac Center Models.
DOI:
https://doi.org/10.63501/jwwkra70Keywords:
Heart Failure, Guideline-directed medical therapy (GDMT, Rehospitilization, Get With The Guidelines® – Heart Failure, Multidisciplinary care, Pharmacist-led interventions, Pakistan healthcare system, UAE cardiac centersAbstract
Heart failure (HF) is a major health concern in Pakistan with high rehospitalization rates and low adherence to guideline-directed medical therapy (GDMT). On the other hand, UAE has implemented effective HF care strategies, including the Get With The Guidelines®️ Heart Failure program, pharmacist-led interventions, and multidisciplinary training, which have improved adherence, reduced hospitalizations and improved quality of life. These differences and the UAE's scalable methods are shown by several studies from Pakistani and UAE sources (2000–2024). By standardizing procedures, including pharmacists, treating comorbidities like iron deficiency, and establishing national registries, Pakistan may be able to lower the burden of heart failure, enhance patient outcomes, and save lives.
References
1. Lal D, Bai B, Kumari P, et al. Factors contributing to re-hospitalization in heart failure patients at a tertiary care center in Karachi, Pakistan. Pak Heart J. 2024;57(3):219-224.
2. American Heart Association. Get With The Guidelines® – Heart Failure improves outcomes in UAE [Internet]. Dallas (TX): American Heart Association; 2024 [cited 2025 Oct 2]. Available from: https://www.heart.org
3. Sulaiman K, Panduranga P, Al-Zakwani I, et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail. 2015;17(4):374-384. doi:10.1002/ejhf.245
4. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183-193. doi:10.1111/j.1365-2125.2005.02387.x
5. Khan A, Muhammad D, Khan A, Dewey R. Assessment of self-care in heart failure patients at a cardiac hospice in Peshawar, Pakistan. Int J Endors Health Sci Res. 2022;10(3):296-303. doi:10.29052/IJEHSR.v10.i3.2022.296-303
6. Said N, Amna A, Khalid E, Mariam I, et al. Ferric carboxymaltose use evaluation in heart failure patients: real-world data from tertiary care hospital in the United Arab Emirates. EC Cardiol. 2024;10(5):1-7.
7. Sadik Z, Stapleton J, Marques M, Atallah B, Gabra G, Soliman M, et al. Six-month outcomes of heart failure patients followed at a newly established multidisciplinary program in the Middle East. J Card Fail. 2018;24(8 Suppl):S71-S72. doi:10.1016/j.cardfail.2018.07.299
8. Sohail H, Khaliq K, Irfan G, Amir K. Comparison of in-hospital outcomes between heart failure patients with reduced and preserved ejection fraction: a single-center cross-sectional study. Pak Heart J. 2024;57(1):33-37. doi:10.47144/phj.v57i1.2598